Indication
Hemophilia B
Hemophilia B, historically known as Christmas disease, is a rare, inherited bleeding disorder caused by a quantitative deficiency or functional defect in coagulation factor IX due to pathogenic variants in the *F9* gene. Read more about Hemophilia B
21 drugs 13 manufacturers
Drugs that treat it
Common Hemophilia B therapies.
RIXUBIS (factor IX human recombinant)
BENEFIX (factor IX human recombinant)
MONONINE (factor IX)
BENEFIX (factor IX human recombinant)
REBINYN (factor IX (human) recombinant, pegylated)
ALPROLIX (factor IX recombinant, Fc fusion protein)
MONONINE (factor IX)
IDELVION (factor IX recombinant,albumin fusion protein)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHemophilia B, historically known as Christmas disease, is a rare, inherited bleeding disorder caused by a quantitative deficiency or functional defect in coagulation factor IX due to pathogenic variants in the *F9* gene.
Transmitted in an X-linked recessive pattern, it predominantly affects males, although heterozygous females may also exhibit bleeding symptoms depending on their circulating factor activity.
Deficient factor IX impairs the intrinsic pathway of the coagulation cascade and hinders adequate thrombin generation, predisposing patients to prolonged or abnormal hemorrhage.
Clinical manifestations correlate with residual factor activity and range from excessive bleeding following invasive procedures or trauma to recurrent, spontaneous hemarthroses, deep muscle hematomas, and potentially fatal internal or intracranial hemorrhages.
- nih.gov
Hemophilia B, historically known as Christmas disease, is a rare, inherited bleeding disorder caused by a quantitative deficiency or functional defect in coagulation factor IX due to pathogenic variants in the *F9* gene Deficient factor IX impairs the intrinsic pathway of the coagulation cascade and hinders adequate thrombin generation, predisposing patients to prolonged or abnormal hemorrhage Clinical manifestations correlate with residual factor activity and range from excessive bleeding follo...
- medlineplus.gov
Hemophilia B, historically known as Christmas disease, is a rare, inherited bleeding disorder caused by a quantitative deficiency or functional defect in coagulation factor IX due to pathogenic variants in the *F9* gene Deficient factor IX impairs the intrinsic pathway of the coagulation cascade and hinders adequate thrombin generation, predisposing patients to prolonged or abnormal hemorrhage
- medlineplus.gov
Hemophilia B, historically known as Christmas disease, is a rare, inherited bleeding disorder caused by a quantitative deficiency or functional defect in coagulation factor IX due to pathogenic variants in the *F9* gene
- medlineplus.gov
Transmitted in an X-linked recessive pattern, it predominantly affects males, although heterozygous females may also exhibit bleeding symptoms depending on their circulating factor activity
- nih.gov
Transmitted in an X-linked recessive pattern, it predominantly affects males, although heterozygous females may also exhibit bleeding symptoms depending on their circulating factor activity Clinical manifestations correlate with residual factor activity and range from excessive bleeding following invasive procedures or trauma to recurrent, spontaneous hemarthroses, deep muscle hematomas, and potentially fatal internal or intracranial hemorrhages
Personalize your experience
Follow Hemophilia B and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.